2024 Biannual CUPA Conference: Hot Topics in Expanded Access

Join us for this 2-day multi-stakeholder event on 29-30 January covering the day’s most pressing ethical issues in non-trial preapproval access at CUPA Con 2024!

In-person attendees will be able to take advantage of interactive workshops, various networking opportunities, a cocktail reception, and other perks. For those unable to attend in-person, tickets providing access to a livestream of main-stage conference sessions are available, however please note that virtual attendees will not have access to interactive workshops.

Main-Stage Session Topics (In-person and livestream)

  • What’s the Business Case for or Against Expanded Access? (Day 1)
  • What’s the Ethics Case for or Against Expanded Access? (Day 1)
  • The Patient Narrative (Day 1)
  • What’s Special about Expanded Access for Gene and Cell Therapies? (Day 1)
  • Real World Evidence & Expanded Access (Day 1)
  • Balancing Access and Evidence Generation (Day 2)
  • FDA’s Project Facilitate (Day 2)
  • Integrating Expanded Access into the ALS Clinical Trial Landscape (Day 2)
  • Beyond Expanded Access: Legislative Approaches to Access (Day 2)

Check out registration details and more information at the following link: https://www.eventbrite.com/e/2024-biannual-cupa-conference-hot-topics-in-expanded-access-tickets-749534647307?aff=oddtdtcreator%3E%E2%80%9D